Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis

Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis

Item
http://www.wikidata.org/entity/Q35214636
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndromeRecent advances in understanding antiphospholipid syndrome.Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK.Current status and future prospects for the treatment of antiphospholipid syndrome.Pathogenesis and management of antiphospholipid syndrome.In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic targetAntibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome.Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.Antiphospholipid antibody-induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome.Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.Is leukocyte tissue factor the key to venous thrombosis in antiphospholipid syndrome?Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome.Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein IPEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
P2860

Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis

Item
http://www.wikidata.org/entity/Q35214636
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Proof-of-concept study demonst ...... id antibody-induced thrombosis
@ast
Proof-of-concept study demonst ...... id antibody-induced thrombosis
@en
type
label
Proof-of-concept study demonst ...... id antibody-induced thrombosis
@ast
Proof-of-concept study demonst ...... id antibody-induced thrombosis
@en
prefLabel
Proof-of-concept study demonst ...... id antibody-induced thrombosis
@ast
Proof-of-concept study demonst ...... id antibody-induced thrombosis
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Proof-of-concept study demonst ...... id antibody-induced thrombosis
@en
P2093
P2860
P304
P31
P356
10.1093/RHEUMATOLOGY/KEU360
P433
P478
P50
P577
P5875
P698
P921
P932